PortfoliosLab logoPortfoliosLab logo
EVI vs. NUS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EVI vs. NUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in EVI Industries, Inc. (EVI) and Nu Skin Enterprises, Inc. (NUS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EVI achieves a -30.07% return, which is significantly higher than NUS's -44.17% return. Over the past 10 years, EVI has outperformed NUS with an annualized return of 16.27%, while NUS has yielded a comparatively lower -15.92% annualized return.


EVI

1D
-1.99%
1M
-9.55%
YTD
-30.07%
6M
-21.00%
1Y
-10.78%
3Y*
-5.79%
5Y*
-9.71%
10Y*
16.27%

NUS

1D
-5.71%
1M
-24.35%
YTD
-44.17%
6M
-46.19%
1Y
-32.22%
3Y*
-44.65%
5Y*
-36.47%
10Y*
-15.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EVI vs. NUS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EVI
EVI Industries, Inc.
-30.07%52.17%-29.97%0.47%-23.57%4.38%10.65%-18.92%-16.34%176.64%
NUS
Nu Skin Enterprises, Inc.
-44.17%43.29%-63.67%-51.07%-13.92%-4.32%38.67%-30.98%-8.32%46.55%

Correlation

The correlation between EVI and NUS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Nov 25, 1996

0.06

The correlation between EVI and NUS shifts across timeframes, from 0.06 (all time) to 0.20 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

EPS

EVI:

$0.67

NUS:

$1.10

PE Ratio

EVI:

25.71

NUS:

4.82

PEG Ratio

EVI:

1.72

NUS:

0.01

PS Ratio

EVI:

0.40

NUS:

0.18

Total Revenue (TTM)

EVI:

$434.65M

NUS:

$1.44B

Gross Profit (TTM)

EVI:

$134.21M

NUS:

$998.90M

EBITDA (TTM)

EVI:

$18.09M

NUS:

$115.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EVI vs. NUS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EVI
EVI Risk / Return Rank: 3434
Overall Rank
EVI Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
EVI Sortino Ratio Rank: 3434
Sortino Ratio Rank
EVI Omega Ratio Rank: 3434
Omega Ratio Rank
EVI Calmar Ratio Rank: 3434
Calmar Ratio Rank
EVI Martin Ratio Rank: 3434
Martin Ratio Rank

NUS
NUS Risk / Return Rank: 1717
Overall Rank
NUS Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
NUS Sortino Ratio Rank: 1717
Sortino Ratio Rank
NUS Omega Ratio Rank: 1616
Omega Ratio Rank
NUS Calmar Ratio Rank: 2121
Calmar Ratio Rank
NUS Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EVI vs. NUS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for EVI Industries, Inc. (EVI) and Nu Skin Enterprises, Inc. (NUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EVINUSDifference

Sharpe ratio

Return per unit of total volatility

-0.18

-0.61

+0.43

Sortino ratio

Return per unit of downside risk

0.18

-0.64

+0.81

Omega ratio

Gain probability vs. loss probability

1.02

0.91

+0.11

Calmar ratio

Return relative to maximum drawdown

-0.20

-0.56

+0.35

Martin ratio

Return relative to average drawdown

-0.37

-1.20

+0.83

EVI vs. NUS - Sharpe Ratio Comparison

The current EVI Sharpe Ratio is -0.18, which is higher than the NUS Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of EVI and NUS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EVINUSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.18

-0.61

+0.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.16

-0.78

+0.62

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.25

-0.32

+0.58

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

-0.07

+0.19

Drawdowns

EVI vs. NUS - Drawdown Comparison

The maximum EVI drawdown since its inception was -93.24%, roughly equal to the maximum NUS drawdown of -94.30%. Use the drawdown chart below to compare losses from any high point for EVI and NUS.


Loading charts...

Drawdown Indicators


EVINUSDifference

Max Drawdown

Largest peak-to-trough decline

-93.24%

-94.30%

+1.06%

Max Drawdown (1Y)

Largest decline over 1 year

-53.10%

-57.93%

+4.83%

Max Drawdown (3Y)

Largest decline over 3 years

-53.10%

-83.43%

+30.33%

Max Drawdown (5Y)

Largest decline over 5 years

-78.70%

-89.89%

+11.19%

Max Drawdown (10Y)

Largest decline over 10 years

-83.32%

-91.91%

+8.59%

Current Drawdown

Current decline from peak

-62.17%

-94.30%

+32.13%

Average Drawdown

Average peak-to-trough decline

-52.85%

-48.07%

-4.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.39%

26.86%

+2.53%

Volatility

EVI vs. NUS - Volatility Comparison

EVI Industries, Inc. (EVI) has a higher volatility of 20.35% compared to Nu Skin Enterprises, Inc. (NUS) at 13.57%. This indicates that EVI's price experiences larger fluctuations and is considered to be riskier than NUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EVINUSDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.35%

13.57%

+6.78%

Volatility (6M)

Calculated over the trailing 6-month period

40.79%

33.55%

+7.24%

Volatility (1Y)

Calculated over the trailing 1-year period

61.71%

53.35%

+8.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.89%

47.01%

+14.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

64.01%

49.15%

+14.86%

Dividends

EVI vs. NUS - Dividend Comparison

EVI's dividend yield for the trailing twelve months is around 1.92%, less than NUS's 4.55% yield.


PositionTTM20252024202320222021202020192018201720162015
EVI
EVI Industries, Inc.
1.92%1.34%1.90%1.18%0.00%0.00%0.00%0.00%0.39%0.30%0.69%4.80%
NUS
Nu Skin Enterprises, Inc.
4.55%2.49%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%

Financials

EVI vs. NUS - Financials Comparison

This section allows you to compare key financial metrics between EVI Industries, Inc. and Nu Skin Enterprises, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
101.13M
320.61M
(EVI) Total Revenue
(NUS) Total Revenue
Values in USD except per share items

EVI vs. NUS - Profitability Comparison

The chart below illustrates the profitability comparison between EVI Industries, Inc. and Nu Skin Enterprises, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
32.5%
66.9%
Portfolio components
EVI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EVI Industries, Inc. reported a gross profit of 32.82M and revenue of 101.13M. Therefore, the gross margin over that period was 32.5%.

NUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a gross profit of 214.46M and revenue of 320.61M. Therefore, the gross margin over that period was 66.9%.

EVI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EVI Industries, Inc. reported an operating income of 2.26M and revenue of 101.13M, resulting in an operating margin of 2.2%.

NUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported an operating income of 4.03M and revenue of 320.61M, resulting in an operating margin of 1.3%.

EVI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EVI Industries, Inc. reported a net income of 753.00K and revenue of 101.13M, resulting in a net margin of 0.7%.

NUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a net income of 1.84M and revenue of 320.61M, resulting in a net margin of 0.6%.


Frequently Asked Questions


EVI and NUS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EVI has higher volatility (20.35%) compared to NUS (13.57%). In terms of maximum drawdown, EVI dropped -93.24% vs NUS's -94.30%.

EVI currently has the higher Sharpe Ratio (-0.18 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EVI and NUS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer